Home > Tabassome Simon, ESC 2020 – the REALITY Trial
Interventional Cardiology
Watch Time: 12.45 mins

Tabassome Simon, ESC 2020 – the REALITY Trial

Published Online: October 20th 2020

We spoke to Professor Tabassome Simon (Hospital Saint-Antoine, Paris, France) on the background, aims and design of the REALITY study (REstrictive And LIberal Transfusion strategies in patients with acute mYocardial infarction and anemia; ClinicalTrials.gov identifier NCT02648113), as well as the findings of the study to date.

Questions:

  1. How prevalent is anaemia in patients with myocardial infarction and what are its prognostic implications? (0:21)
  2. Why is there a lack of consensus about which transfusion strategy is best in these patients? (1:15)
  3. Could you give us an overview of the aims and designs of the REALITY study? (2:52)
  4. What have been the findings of the study to date? (5:27)
  5. What are the clinical implications of these findings and what future studies are planned? (9:33)

Speaker disclosures: Professor Tabassome Simon has nothing to declare in relation to this video interview.

Commissioned, edited and funded by Touch Medical Media.

Filmed during a remote video call with Professor Tabassome Simon, September 2020.

Share this Video
Related Videos In Interventional Cardiology
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar